These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12045328)
1. Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives. Murineddu G; Cignarella G; Chelucci G; Loriga G; Pinna GA Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):754-9. PubMed ID: 12045328 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones. Rathish IG; Javed K; Ahmad S; Bano S; Alam MS; Akhter M; Pillai KK; Ovais S; Samim M Eur J Med Chem; 2012 Mar; 49():304-9. PubMed ID: 22305543 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative and antiviral activity of carbohydrate-modified pyrrolo[2,3-d]pyridazin-7-one nucleosides. Meade EA; Wotring LL; Drach JC; Townsend LB J Med Chem; 1997 Feb; 40(5):794-801. PubMed ID: 9057866 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxicity evaluation of substituted pyridazino[4,5-b]phenazine-5,12-diones and tri/tetra-azabenzofluorene-5,6-diones. Lee HJ; Kim JS; Suh ME; Park HJ; Lee SK; Rhee HK; Kim HJ; Seo EK; Kim C; Lee CO; Park Choo HY Eur J Med Chem; 2007 Feb; 42(2):168-74. PubMed ID: 17070967 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative effects of 5,6-disubstituted Pyridazin-3(2H)-ones designed as conformationally constrained combretastatin A-4 Analogues. Elagawany M; Schmitt M; Ghiaty A; El-Etrawy ASh; Ibrahim MA; Bihel F; Sbardelotto AB; Pessoa C; Nguyen TL; Hamel E; Bourguignon JJ Anticancer Agents Med Chem; 2013 Sep; 13(7):1133-40. PubMed ID: 23574386 [TBL] [Abstract][Full Text] [Related]
6. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity. Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents. Zhou S; Liao H; He C; Dou Y; Jiang M; Ren L; Zhao Y; Gong P Eur J Med Chem; 2014 Aug; 83():581-93. PubMed ID: 24996144 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and in-vitro cytotoxic evaluation of novel pyridazin-4-one derivatives. Mojahidi S; Rakib el M; Sekkak H; Abouricha S; Benchat N; Mousse HA; Zyad A Arch Pharm (Weinheim); 2010 May; 343(5):310-3. PubMed ID: 20222064 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives. Bakr RB; Mehany ABM; Abdellatif KRA Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084 [TBL] [Abstract][Full Text] [Related]
10. 3-[(6-Arylamino)pyridazinylamino]benzoic acids: design, synthesis and in vitro evaluation of anticancer activity. Abouzid KA; Khalil NA; Ahmed EM; Mohamed KO Arch Pharm Res; 2013 Jan; 36(1):41-50. PubMed ID: 23307426 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxicity of novel hexahydrothienocycloheptapyridazinone derivatives. Pau A; Murineddu G; Asproni B; Murruzzu C; Grella GE; Pinna GA; Curzu MM; Marchesi I; Bagella L Molecules; 2009 Sep; 14(9):3494-508. PubMed ID: 19783939 [TBL] [Abstract][Full Text] [Related]
12. Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors. Kim EY; Kang ST; Jung H; Park CH; Yun CS; Hwang JY; Byun BJ; Lee CO; Kim HR; Ha JD; Ryu DH; Cho SY Arch Pharm Res; 2016 Apr; 39(4):453-464. PubMed ID: 26753914 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxic activities of some pyrazoline derivatives bearing phenyl pyridazine core as new apoptosis inducers. George RF; Fouad MA; Gomaa IEO Eur J Med Chem; 2016 Apr; 112():48-59. PubMed ID: 26874744 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues. Congiu C; Cocco MT; Onnis V Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives. Popovici L; Amarandi RM; Mangalagiu II; Mangalagiu V; Danac R J Enzyme Inhib Med Chem; 2019 Dec; 34(1):230-243. PubMed ID: 30734610 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and Anti-cancer Activity of 3-substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives. Zhan X; Qin W; Wang S; Zhao K; Xin Y; Wang Y; Qi Q; Mao Z Anticancer Agents Med Chem; 2017; 17(6):821-831. PubMed ID: 27671311 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives. Congiu C; Onnis V; Vesci L; Castorina M; Pisano C Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activities of new 3-allylthio-6-(mono or disubstituted)aminopyridazines. Won YH; Park MS Arch Pharm Res; 2010 Feb; 33(2):189-96. PubMed ID: 20195817 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of some pyrrolo[3,4-d]pyridazinones and their preliminary anticancer, antimycobacterial and CNS screening. Malinka W Pharmazie; 2001 May; 56(5):384-9. PubMed ID: 11400553 [TBL] [Abstract][Full Text] [Related]
20. Design and Synthesis of Pyridazine Containing Compounds with Promising Anticancer Activity. Elmeligie S; Ahmed EM; Abuel-Maaty SM; Zaitone SA; Mikhail DS Chem Pharm Bull (Tokyo); 2017; 65(3):236-247. PubMed ID: 28250345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]